Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Carie Boyd Pharmaceuticals LLC
FDA Inspection
•Carie Boyd Pharmaceuticals LLC•December 12, 2014

Carie Boyd Pharmaceuticals LLC – FDA Inspection, Dec 12, 2014

Record Details

This FDA Inspection record concerns Carie Boyd Pharmaceuticals LLC, with an inspection on December 12, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Carie Boyd Pharmaceuticals LLC
Inspection Date
December 12, 2014
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 8003c0ac-4c79-44bc-84e2-3b9c343668ab

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
908025
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

12
  1. 21 CFR 211.42(c)(10)(v)Cleaning System
  2. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  3. 21 CFR 211.188Prepared for each batch, include complete information
  4. 21 CFR 211.188(b)(8)Labeling control records including specimens or copies
  5. 21 CFR 211.188(b)(3)Identification of each component or in-process material
  6. 21 CFR 211.28(a)Clothing appropriate for duties performed
  7. 21 CFR 211.167(a)Sterility/pyrogen-free testing
  8. 21 CFR 211.84(d)(6)Microbiological Contamination Exam
  9. 21 CFR 211.113(b)Validation lacking for sterile drug products
  10. 21 CFR 211.165(a)Testing and release for distribution

Showing 10 of 12 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Carie Boyd Pharmaceuticals LLC

6
DateClassificationOfficeProject area
September 8, 2026Not classifiedDallas District OfficeDrug Quality Assurance
July 18, 2025Not classifiedDallas District OfficeDrug Quality Assurance
June 21, 2024OAIDrug Quality Assurance
June 27, 2022OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 12, 2019OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 6 other inspections on the company page
Other documents for Carie Boyd Pharmaceuticals LLC
  • FDA Inspection 1334806 - 2026-09-08
  • FDA Inspection 1275006 - 2025-07-18
  • FDA Inspection 1241822 - 2024-06-21
  • FDA Inspection 1172848 - 2022-06-27
  • FDA Inspection 1109663 - 2019-11-12

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Carie Boyd Pharmaceuticals LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.